Sea change in treatment of late-stage breast cancer

Ms Christina Ng, 59, a patient with stage four breast cancer, was one of those who enrolled for the phase III Monaleesa-2 study. More than four years later, Ms Ng no longer experiences pain and a scan in November last year showed the mass in her unde
Ms Christina Ng, 59, a patient with stage four breast cancer, was one of those who enrolled for the phase III Monaleesa-2 study. More than four years later, Ms Ng no longer experiences pain and a scan in November last year showed the mass in her underarm had shrunk by 90 per cent.ST PHOTO: SYAZA NISRINA

New inhibitor drug used for patients with the most common type of stage four breast cancer

Ms Christina Ng, 59, first felt pain in her upper left arm about six years ago. It started as a dull ache that wouldn't go away.

"I thought it was caused by stress so I decided to quit my job as an accountant. But the pain got more intense. It would creep into my fingertips," the breast cancer survivor told The Straits Times in an interview last week.

Please or to continue reading the full article. Learn more about ST PREMIUM.

Enjoy unlimited access to ST's best work

  • Exclusive stories and features on multiple devices
  • In-depth analyses and opinion pieces
  • ePaper and award-winning multimedia content
A version of this article appeared in the print edition of The Straits Times on September 11, 2018, with the headline 'Sea change in treatment of late-stage breast cancer'. Print Edition | Subscribe